FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0135-0608-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-93 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-18 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-06 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-77 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-8202-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2000-20 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 0135-0609-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 0067-8125-16 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-04 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-95 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-01 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-91 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
DIPHENHYDRAMINE CITRATE; ACETAMINOPHEN; ASPIRIN | 0067-2056-24 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0135-0608-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 0031-8752-12 | Haleon US Holdings LLC | M0012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2000-50 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2000-94 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 0135-7011-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0031-8770-12 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2001-08 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 0135-0537-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-8201-03 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0067-0105-08 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 0067-8136-10 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | 0067-6426-06 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE | 0135-0578-01 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
-